Clinical Trials Browser

Phase 2 × Myeloproliferative Disorders × isavuconazole × Clear all

NCT03149055 2025-05-16

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Phase 2 Completed

99 enrolled 13 charts

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Hematologic Neoplasms